Advertisement

Vitamin E Aqueous Oral Solution

[25 January 2017]

Products Affected - Description

Aquasol E drops, Pfizer
15 IU/0.3 mL, 12 mL bottle, 1 count (NDC 61703-0419-77) - discontinued
15 IU/0.3 mL, 30 mL bottle, 1 count (NDC 61703-0419-78) - discontinued
 
Aqueous Vitamin E oral drops, Lannett
15 IU/0.3 mL, 30 mL bottle, 1 count (NDC 54838-0005-30) - discontinued
 
Vitamin E oral drops, Geritrex
15 IU/0.3 mL, 12 mL bottle, 1 count (UPC 92771-072512) - discontinued

Reason for the Shortage

  • Geritrex discontinued vitamin E oral drops in January 2017.
  • Pfizer (Hospira) discontinued Aquasol E oral drops in October 2016.
  • Lannett (Silarx) discontinued vitamin E oral drops in July 2016.

Available Products

There are no presentations available

Estimated Resupply Dates

Lannett and Geritrex discontinued vitamin E aqueous oral solution. Hospira discontinued Aquasol E oral solution.

Updated

January 25 and 9, 2017; November 1, October 11, August 1, May 31, April 26, February 29, January 13, 2016; October 19, August 11, June 8, April 13, March 25 and 4, 2015; December 12, September 8, May 29, March 3, 2014; December 9, September 30 and 13, July 10, May 8, March 6, January 23, 2013; December 19, November 2, 2012, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing